Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
|
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 50 条
  • [1] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [2] Correlates of protection against SARS-CoV-2 infection and COVID-19 disease
    Goldblatt, David
    Alter, Galit
    Crotty, Shane
    Plotkin, Stanley A.
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 6 - 26
  • [3] Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease Running title: Propolis against SARS-CoV-2 infection and COVID-19
    Berretta, Andresa Aparecida
    Duarte Silveira, Marcelo Augusto
    Capcha, Jose Manuel Condor
    De Jong, David
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [4] SARS-CoV-2 antibody response in SARS survivors with and without the COVID-19 vaccine
    Xia, Chang-Sheng
    Zhan, Minghua
    Liu, Yudong
    Yue, Zhi-Hong
    Song, Ying
    Zhang, Feifei
    Wang, Hui
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (04)
  • [5] COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis
    Peric, Stojan
    Rankovic, Milos
    Bozovic, Ivo
    Radosavljevic, Vanja
    Marjanovic, Ivan
    Basta, Ivana
    Lavrnic, Dragana
    ACTA NEUROLOGICA BELGICA, 2023, 123 (02) : 529 - 536
  • [6] COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants
    Yogesh, Ruchika
    Srivastava, Noopur
    Bukhari, Syed Nasir Abbas
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (35) : 2901 - 2913
  • [7] Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
    Sadat, Seyed Mehdi
    Aghadadeghi, Mohammad Reza
    Yousefi, Masoume
    Khodaei, Arezoo
    Sadat Larijani, Mona
    Bahramali, Golnaz
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (05) : 389 - 409
  • [8] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [9] Candidate drugs against SARS-CoV-2 and COVID-19
    McKee, Dwight L.
    Sternberg, Ariane
    Stange, Ulrike
    Laufer, Stefan
    Naujokat, Cord
    PHARMACOLOGICAL RESEARCH, 2020, 157
  • [10] Naringenin as a Possible Candidate Against SARS-CoV-2 Infection and in the Pathogenesis of COVID-19
    Agrawal, Pawan K.
    Agrawal, Chandan
    Blunden, Gerald
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (12)
12345